Haemonetics Corporation (HAE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 4:00 PM EDT
Company Participants
Christopher Simon – CEO, President & Director
Presentation
Unknown Analyst
Good afternoon, everyone. Pleased to welcome you to our last session of day 1 of the conference. Very pleased to welcome Chris Simon, President and CEO of Haemonetics. Thank you again for making the trip to Miami. We were catching up before this. It’s been a long time. Since I started, you were here last year, but obviously, we go back much further than that in terms of the evolution of the company.
Question-and-Answer Session
Unknown Analyst
So maybe just you’re kind of — you’ve completed an LRP. You just set out fiscal year guidance. Just like where are you in kind of this transformation of Haemonetics?
Christopher Simon
CEO, President & Director
Thanks, and thanks for having us at the conference. Delighted to be here. And another chance to tell our story. So yes, you talked about the LRP. That was a 4-year plan that wrapped up about 3 months ago. And if I reflect on that, we were coming out of COVID, we were managing the transition of a large customer. It was a challenging environment to say the least.
We went out with what we thought was bold aspirational goals, and I’m pleased to say for the team that we achieved almost all of them. We thought we would grow high single digits. We actually grew 10%. We said we would grow mid-teens on our earnings. We actually grew mid-20s and felt good about that. We had this very powerful combination of free cash flow in excess of $650 million and then the margin expansion where we fell a notch short.
We were at 18% operating income
